Delivering the fastest sedation of agitated & aggressive patients, improving safety of the staff in the emergency department
Delivering the fastest sedation of agitated & aggressive patients, improving safety of the staff in the emergency department
We are a startup pharmaceutical company that is positioned to introduce the first new delivery innovation in injectable benzodiazepines in over 30 years.
Benzodiazepines, which are used to relax and sedate patients, were developed between 1960 and 1990, but little innovation in intramuscular delivery has taken place since then. Sollievo’s proprietary approach maintains safety while providing lightning fast absorption
Sollievo Pharmaceuticals is well positioned to disrupt the $500 million global injectable benzodiazepine market, with the introduction of the fastest acting intramuscular benzodiazepine– Proviza™
Copyright © 2021 Sollievo Pharmaceuticals - All Rights Reserved.
Powered by Captjur